Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PFE – Pfizer Inc.

Pfizer, Inc.
PFE
$24.29
Name : Pfizer, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $137,759,522,816.00
EPSttm : 1.41
finviz dynamic chart for PFE
Pfizer, Inc.
$24.29
1.66%
$0.41

Float Short %

1.75

Margin Of Safety %

42

Put/Call OI Ratio

0.91

EPS Next Q Diff

-0.06

EPS Last/This Y

-0.16

EPS This/Next Y

0.1

Price

24.29

Target Price

30.39

Analyst Recom

2.29

Performance Q

-8.44

Relative Volume

1.17

Beta

0.54

Ticker: PFE




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-05PFE25.910.820.462976030
2025-03-06PFE26.250.830.413004004
2025-03-07PFE26.730.820.493022300
2025-03-10PFE26.620.850.572948112
2025-03-11PFE25.990.860.552979743
2025-03-12PFE25.730.860.773027693
2025-03-13PFE25.60.880.853094806
2025-03-14PFE25.70.880.443123449
2025-03-17PFE26.060.870.403063826
2025-03-18PFE26.330.870.483091165
2025-03-19PFE26.210.860.543152723
2025-03-20PFE26.190.860.553174255
2025-03-21PFE26.060.850.393190363
2025-03-24PFE26.130.930.582739858
2025-03-25PFE25.560.910.972809927
2025-03-26PFE25.20.921.202953834
2025-03-27PFE25.030.921.413049120
2025-03-28PFE25.190.970.423148558
2025-03-31PFE25.30.930.583012664
2025-04-01PFE24.540.930.473069993
2025-04-02PFE24.640.920.423139897
2025-04-03PFE24.290.910.793187298
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-05PFE25.93-13.010013.32.95
2025-03-06PFE26.26-13.010099.82.95
2025-03-07PFE26.73-13.010203.72.95
2025-03-10PFE26.66-13.09856.62.95
2025-03-11PFE25.99-13.09500.72.95
2025-03-12PFE25.72-13.09730.62.95
2025-03-13PFE25.60-13.09830.12.95
2025-03-14PFE25.72-13.09975.32.95
2025-03-17PFE26.05-13.010107.52.95
2025-03-18PFE26.31-13.010061.72.95
2025-03-19PFE26.21-13.09837.32.95
2025-03-20PFE26.19-13.09886.92.95
2025-03-21PFE26.25-13.09936.72.95
2025-03-24PFE26.14-13.09812.52.95
2025-03-25PFE25.55-13.09532.02.95
2025-03-26PFE25.21-13.09683.82.95
2025-03-27PFE25.01-13.09771.32.95
2025-03-28PFE25.21-13.010028.32.95
2025-03-31PFE25.34-13.09982.62.95
2025-04-01PFE24.54-12.39389.22.95
2025-04-02PFE24.70-12.310003.82.95
2025-04-03PFE24.29-12.39632.82.95
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-05PFE0.52-0.771.57
2025-03-06PFE0.45-0.771.57
2025-03-07PFE0.45-0.771.57
2025-03-10PFE0.45-0.471.57
2025-03-11PFE0.80-0.471.57
2025-03-12PFE0.80-0.471.68
2025-03-13PFE0.80-0.471.68
2025-03-14PFE0.80-0.471.68
2025-03-17PFE0.80-0.461.68
2025-03-18PFE0.80-0.461.68
2025-03-19PFE0.80-0.461.68
2025-03-20PFE0.80-0.461.68
2025-03-21PFE0.80-0.461.68
2025-03-24PFE0.80-0.471.67
2025-03-25PFE0.80-0.471.67
2025-03-26PFE0.80-0.471.75
2025-03-27PFE0.80-0.471.75
2025-03-28PFE0.80-0.471.75
2025-03-31PFE0.80-0.471.75
2025-04-01PFE0.80-0.471.75
2025-04-02PFE0.80-0.471.75
2025-04-03PFE0.80-0.471.75
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.63

Avg. EPS Est. Current Quarter

0.72

Avg. EPS Est. Next Quarter

0.57

Insider Transactions

0.8

Institutional Transactions

-0.47

Beta

0.54

Average Sales Estimate Current Quarter

14427

Average Sales Estimate Next Quarter

13538

Fair Value

34.46

Quality Score

81

Growth Score

61

Sentiment Score

55

Actual DrawDown %

60.6

Max Drawdown 5-Year %

-59.9

Target Price

30.39

P/E

17.25

Forward P/E

8

PEG

P/S

2.17

P/B

1.56

P/Free Cash Flow

14.01

EPS

1.41

Average EPS Est. Cur. Y​

2.95

EPS Next Y. (Est.)

3.05

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.6

Relative Volume

1.17

Return on Equity vs Sector %

-10.7

Return on Equity vs Industry %

-17.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

9632.8
Pfizer, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 81000
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
stock quote shares PFE – Pfizer Inc. Stock Price stock today
news today PFE – Pfizer Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PFE – Pfizer Inc. yahoo finance google finance
stock history PFE – Pfizer Inc. invest stock market
stock prices PFE premarket after hours
ticker PFE fair value insiders trading